Genetic Study of Early Onset Parkinson's Disease in Cyprus

Int J Mol Sci. 2022 Dec 6;23(23):15369. doi: 10.3390/ijms232315369.

Abstract

Parkinson's Disease (PD) is a multifactorial neurodegenerative disease characterized by motor and non-motor symptoms. The etiology of PD remains unclear. However, several studies have demonstrated the interplay of genetic, epigenetic, and environmental factors in PD. Early-onset PD (EOPD) is a subgroup of PD diagnosed between the ages of 21 and 50. Population genetic studies have demonstrated great genetic variability amongst EOPD patients. Hence, this study aimed to obtain a genetic landscape of EOPD in the Cypriot population. Greek-Cypriot EOPD patients (n = 48) were screened for variants in the six most common EOPD-associated genes (PINK1, PRKN, FBXO7, SNCA, PLA2G6, and DJ-1). This included DNA sequencing and Multiplex ligation-dependent probe amplification (MLPA). One previously described frameshift variant in PINK1 (NM_032409.3:c.889del) was detected in five patients (10.4%)-the largest number to be detected to date. Copy number variations in the PRKN gene were identified in one homozygous and 3 compound heterozygous patients (8.3%). To date, the pathogenic variants identified in this study have explained the PD phenotype for 18.8% of the EOPD cases. The results of this study may contribute to the genetic screening of EOPD in Cyprus.

Keywords: Greek-Cypriot Parkinson’s patients; early onset Parkinson’s disease (EOPD); genetic investigation.

MeSH terms

  • Age of Onset
  • DNA Copy Number Variations
  • Humans
  • Mutation
  • Neurodegenerative Diseases*
  • Parkinson Disease* / epidemiology
  • Parkinson Disease* / genetics
  • Phenotype
  • Ubiquitin-Protein Ligases / genetics

Substances

  • Ubiquitin-Protein Ligases

Grants and funding